To better understand the molecular mechanisms underlying in the Id1-loss phenotype in combination with the blockade of the PD-1/PD-L1 axis, we investigated the potential role of each immune cell subpopulation in the observed antitumor effect on the tumor growth when both Id1 and PD-1 were inhibited. The gene discussed is ID1; the disease is neoplasm.